Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microbot Medical (MBOT) Gains from Investment Securities (2016)

Microbot Medical's Gains from Investment Securities history spans 7 years, with the latest figure at $1.3 million for Q4 2016.

  • For the quarter ending Q4 2016, Gains from Investment Securities rose 961.0% year-over-year to $1.3 million, compared with a TTM value of $5.2 million through Dec 2016, up 581.39%, and an annual FY2025 reading of $893000.0, up 811.22% over the prior year.
  • Gains from Investment Securities for Q4 2016 was $1.3 million at Microbot Medical, down from $4.3 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $11.2 million in Q3 2012, with the low at -$10.0 million in Q4 2012.
  • Average Gains from Investment Securities over 5 years is $272961.0, with a median of $27831.0 recorded in 2016.
  • Year-over-year, Gains from Investment Securities crashed 13636.37% in 2012 and then surged 2930.56% in 2014.
  • Tracing MBOT's Gains from Investment Securities over 5 years: stood at -$10.0 million in 2012, then soared by 128.41% to $2.8 million in 2013, then fell by 17.72% to $2.3 million in 2014, then crashed by 106.66% to -$155000.0 in 2015, then soared by 961.0% to $1.3 million in 2016.
  • Per Business Quant, the three most recent readings for MBOT's Gains from Investment Securities are $1.3 million (Q4 2016), $4.3 million (Q3 2016), and $27831.0 (Q2 2016).